POLBF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Jul 10 closing price
Capitalization
36.27M
SNSE
Price
$9.02
Change
-$0.11 (-1.20%)
Updated
Sep 24 closing price
Capitalization
11.38M
Interact to see
Advertisement

POLBF vs SNSE

Header iconPOLBF vs SNSE Comparison
Open Charts POLBF vs SNSEBanner chart's image
Poolbeg Pharma
Price$0.04
Change-$0.00 (-0.00%)
Volume$50K
Capitalization36.27M
Sensei Biotherapeutics
Price$9.02
Change-$0.11 (-1.20%)
Volume$2.73K
Capitalization11.38M
POLBF vs SNSE Comparison Chart in %
Loading...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
POLBF vs. SNSE commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POLBF is a Hold and SNSE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (POLBF: $0.04 vs. SNSE: $9.02)
Brand notoriety: POLBF and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: POLBF: 100% vs. SNSE: 15%
Market capitalization -- POLBF: $36.27M vs. SNSE: $11.38M
POLBF [@Biotechnology] is valued at $36.27M. SNSE’s [@Biotechnology] market capitalization is $11.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $96.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

POLBF’s FA Score shows that 1 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • POLBF’s FA Score: 1 green, 4 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than POLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNSE’s TA Score shows that 5 TA indicator(s) are bullish.

  • SNSE’s TA Score: 5 bullish, 3 bearish.

Price Growth

POLBF (@Biotechnology) experienced а 0.00% price change this week, while SNSE (@Biotechnology) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +10.45%, and the average quarterly price growth was +53.75%.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
POLBF($36.3M) has a higher market cap than SNSE($11.4M). SNSE YTD gains are higher at: -7.978 vs. POLBF (-63.983).
POLBFSNSEPOLBF / SNSE
Capitalization36.3M11.4M318%
EBITDAN/A-26.03M-
Gain YTD-63.983-7.978802%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A28.6M-
Total DebtN/A2.56M-
TECHNICAL ANALYSIS
Technical Analysis
POLBFSNSE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
9%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
9%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FANUF29.20N/A
N/A
Fanuc Corporation
HBGRY1.07N/A
N/A
Heidelberger Druckmaschinen AG
CTXAF16.30N/A
N/A
Ampol Ltd.
BBXIB5.50N/A
N/A
BBX Capital, Inc.
SPFX1.70N/A
N/A
Standard Premium Finance Holdings, Inc.

POLBF and

Correlation & Price change

A.I.dvisor tells us that POLBF and VSTM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and VSTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POLBF
1D Price
Change %
POLBF100%
N/A
VSTM - POLBF
29%
Poorly correlated
-6.31%
NNVC - POLBF
24%
Poorly correlated
-1.39%
SNSE - POLBF
24%
Poorly correlated
-1.20%
ALXO - POLBF
20%
Poorly correlated
+23.02%
OKYO - POLBF
12%
Poorly correlated
-3.91%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with HURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-1.20%
HURA - SNSE
48%
Loosely correlated
+2.80%
VSTM - SNSE
46%
Loosely correlated
-6.31%
MOLN - SNSE
42%
Loosely correlated
+0.27%
GRI - SNSE
38%
Loosely correlated
+9.23%
INAB - SNSE
37%
Loosely correlated
+1.95%
More